YeSUN TechLtd Past Earnings Performance
Past criteria checks 0/6
YeSUN TechLtd's earnings have been declining at an average annual rate of -53.8%, while the Chemicals industry saw earnings growing at 8% annually. Revenues have been declining at an average rate of 5.5% per year.
Key information
-53.8%
Earnings growth rate
-66.1%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | -5.5% |
| Return on equity | -38.7% |
| Net Margin | -16.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Does YeSUN TechLtd (KOSDAQ:250930) Have A Healthy Balance Sheet?
Aug 12
YeSUN Tech Co.,Ltd.'s (KOSDAQ:250930) Shareholders Might Be Looking For Exit
Apr 10YeSUN TechLtd (KOSDAQ:250930) Takes On Some Risk With Its Use Of Debt
Mar 12The Trends At YeSUN TechLtd (KOSDAQ:250930) That You Should Know About
Feb 10
YeSUN TechLtd's (KOSDAQ:250930) Stock Price Has Reduced 22% In The Past Year
Jan 20We're Not Counting On YeSUN TechLtd (KOSDAQ:250930) To Sustain Its Statutory Profitability
Dec 29YeSUN Tech Co.,Ltd. (KOSDAQ:250930) Has A ROE Of 8.1%
Dec 03Revenue & Expenses Breakdown
How YeSUN TechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 48,477 | -7,922 | 11,234 | 743 |
| 31 Mar 24 | 45,162 | -9,797 | 11,051 | 743 |
| 31 Dec 23 | 44,116 | -10,208 | 11,172 | 836 |
| 30 Sep 23 | 44,514 | -10,452 | 10,288 | 847 |
| 30 Jun 23 | 43,752 | -10,036 | 10,608 | 847 |
| 31 Mar 23 | 47,429 | -9,598 | 10,877 | 1,008 |
| 31 Dec 22 | 53,168 | -9,117 | 10,320 | 1,443 |
| 30 Sep 22 | 58,715 | -3,416 | 10,706 | 1,400 |
| 30 Jun 22 | 62,164 | -2,885 | 10,677 | 1,400 |
| 31 Mar 22 | 64,572 | -1,004 | 9,975 | 1,368 |
| 31 Dec 21 | 65,923 | 2,434 | 10,665 | 739 |
| 30 Sep 21 | 66,677 | -358 | 11,490 | 611 |
| 30 Jun 21 | 67,970 | 2,527 | 11,336 | 611 |
| 31 Mar 21 | 62,774 | 2,804 | 11,269 | 489 |
| 31 Dec 20 | 57,337 | 1,688 | 10,603 | 413 |
| 30 Sep 20 | 53,687 | 3,293 | 9,965 | 435 |
| 30 Jun 20 | 51,552 | -4,715 | 9,415 | 435 |
| 31 Mar 20 | 55,142 | -4,037 | 9,213 | 462 |
| 31 Dec 19 | 58,933 | -2,982 | 9,662 | 299 |
| 30 Sep 19 | 62,625 | 800 | 8,521 | -63 |
| 30 Jun 19 | 60,931 | 9,097 | 8,630 | -63 |
| 31 Dec 18 | 56,748 | 5,784 | 7,727 | 288 |
| 31 Dec 16 | 25,011 | -2,379 | 5,051 | 848 |
| 31 Dec 15 | 30,511 | 1,420 | 4,665 | 1,212 |
| 31 Dec 14 | 31,546 | 1,122 | 4,191 | 1,259 |
| 31 Dec 13 | 31,977 | 413 | 4,347 | 941 |
Quality Earnings: A250930 is currently unprofitable.
Growing Profit Margin: A250930 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A250930 is unprofitable, and losses have increased over the past 5 years at a rate of 53.8% per year.
Accelerating Growth: Unable to compare A250930's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A250930 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.6%).
Return on Equity
High ROE: A250930 has a negative Return on Equity (-38.74%), as it is currently unprofitable.